Tectonic Therapeutic reported $12.96M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Akebia Therapeutics USD 173.88M 10.95M Mar/2026
Alnylam Pharmaceuticals USD 1.51B 163.04M Jun/2026
Celltrion KRW 292.71B 9.09B Mar/2026
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 34.39M 3.89M Jun/2026
Divis Laboratories Ltd INR 20.43B 3.15B Mar/2026
Gilead Sciences USD 9.48B 2.34B Mar/2026
Ionis Pharmaceuticals USD 315.64M 401.36M Jun/2026
Kangmei Pharma CNY 5.38B 433.79M Mar/2026
Karyopharm Therapeutics USD 117.3M 25.24M Mar/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
MacroGenics USD 95.94M 52.82M Mar/2026
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 5.56M 2.26M Dec/2025
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Organigram Holdings CAD 88.74M 5.31M Mar/2026
Ovoca Bio EUR 1.3M 1.11M Dec/2025
Pfizer USD 32.65B 1.7B Jun/2026
Pharma Mar EUR 98.42M 9.2M Jun/2026
Qiagen NV USD 479.11M 33.03M Mar/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
Sanofi EUR 31.93B 1.92B Jun/2026
Sarepta Therapeutics USD 499.16M 596.13M Mar/2026
Sartorius EUR 1.44B 668.7M Jun/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Takeda JPY 2.76T 335.02B Jun/2026
Tilray USD 259.32M 8.32M Sep/2025
Zealand Pharma A/S 404M 260.96M Mar/2026
Zz Pientze Pharmaceu CNY 2.28B 134.52M Mar/2026